<DOC>
	<DOCNO>NCT01172249</DOCNO>
	<brief_summary>This open , prospective , randomize , control , parallel , multicenter , non-inferiority study 250 individual ( 125 individual per group ) , 204 evaluable patient clinical radiological diagnosis osteoarthritis knee . Individuals randomize receive 180 day test drug ( glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg - Mantecorp ) reference medication ( glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg - Condroflex® ) . Efficacy evaluate clinical picture , pain visual analog scale , swell , stiffness joint , consumption paracetamol quality life . The safety assessment do monitoring incidence adverse event relation treatment .</brief_summary>
	<brief_title>Non-inferiority Study Glucosamine Sulfate + Chondroitin Sulfate Association Capsule Comparison CONDROFLEX® Product Osteoarthrosis Knee</brief_title>
	<detailed_description>This open , prospective , randomize , control , parallel , multicenter , non-inferiority study 250 individual ( 125 individual per group ) , 204 evaluable patient clinical radiological diagnosis osteoarthritis knee . The subject study immunocompetent men woman , age 55 80 year , diagnose osteoarthritis knee . The inclusion competitive . Individuals qualify screen period randomize receive 180 day one follow regimen : - Therapeutic regimen A : one capsule T.I.D . meal ( drug test - glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg - Mantecorp ) - Therapeutic regimen B : one capsule T.I.D . meal ( reference medication - glucosamine sulfate 500 mg + sodium chondroitin sulfate 400 mg - Condroflex® ) . Efficacy evaluate clinical picture , pain visual analog scale , swell , stiffness joint , consumption paracetamol quality life . The safety assessment do monitoring incidence adverse event relation treatment .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>Individuals must 5580 year age , sexes race . Individuals diagnose osteoarthritis knee grade 2 3 accord scale Kellgren / Lawrence [ K / L ] , conjunction measurement Joint Space Width ( JSW ) , considers joint space width , confirm radiological examination ( ) knee ( ) affect ( ) . Grade 1 : doubtful narrow joint space possible osteophyte edge Grade 2 : define osteophyte , moderate joint space narrow Grade 3 : moderate multiple osteophyte , definite reduction joint space , sclerosis possible deformity bone contour Grade 4 : large osteophyte , mark joint space narrowing , severe sclerosis definite deformity bone contour Individuals capacity provide write informed consent , understand respond questionnaire study disability also willingness adhere treatment attend schedule appointment study . Persons observe period washout drug list question Prohibited Medication Individuals history hypersensitivity glucosamine sulfate chondroitin sulfate component formula Individuals use drug research within last 30 day Individuals uric acid great equal 6 mg/dL woman 7 mg/dL men previous diagnosis gout and/or hypouricemic medication Individuals physical therapy Individuals bilateral osteoarthritis , classification one knees fit grade 2 3 , accord scale Kellgren / Lawrence ( K/L ) together measure Joint Space Width ( JSW ) Individuals treat glucocorticoid infiltration , inject hyaluronic acid joint Individuals underwent arthroplasty location evaluate Individuals thyroid dysfunction control ( included presence normal TSH ) Subjects decompensated type 2 diabetes mellitus ( diagnose examination glycated hemoglobin , 7.5 % ) Individuals infection ( know suspect ) joint require therapy systemic antibiotic Individuals significant disease clinically significant disorder , accord investigator , could interfere study require treatment might interfere assessment efficacy / safety Individuals knowledge HIV positive immunocompromised Patients need use medication list item Forbidden Medication Individuals neurological orthopedic alteration affect low limbs Individuals BMI ( Body Mass Index ) great 27 Individuals initiate physical activity inclusion study . If already regular activity enter study , patient may include long keep activity Individuals kidney disease .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Knee</keyword>
	<keyword>Glucosamine</keyword>
	<keyword>Chondroitin</keyword>
</DOC>